Chimerix Analyst Ratings
Chimerix Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/04/2023 | 848.28% | HC Wainwright & Co. | → $11 | Reiterates | Buy → Buy |
| 05/23/2023 | 503.45% | Baird | → $7 | Initiates Coverage On | → Outperform |
| 05/05/2023 | 848.28% | HC Wainwright & Co. | → $11 | Reiterates | → Buy |
| 03/03/2023 | 848.28% | HC Wainwright & Co. | → $11 | Reiterates | → Buy |
| 09/07/2022 | 503.45% | Capital One | → $7 | Initiates Coverage On | → Overweight |
| 05/17/2022 | 848.28% | HC Wainwright & Co. | $24 → $11 | Maintains | Buy |
| 12/22/2021 | 1968.97% | HC Wainwright & Co. | $21 → $24 | Maintains | Buy |
| 11/22/2021 | 1710.34% | HC Wainwright & Co. | $19 → $21 | Maintains | Buy |
| 06/07/2021 | 1537.93% | HC Wainwright & Co. | $18 → $19 | Maintains | Buy |
| 05/06/2021 | 1451.72% | HC Wainwright & Co. | $16 → $18 | Maintains | Buy |
| 04/29/2021 | 1624.14% | Maxim Group | → $20 | Initiates Coverage On | → Buy |
| 03/31/2021 | 1710.34% | Jefferies | → $21 | Initiates Coverage On | → Buy |
| 03/31/2021 | 1106.9% | Wedbush | → $14 | Initiates Coverage On | → Outperform |
| 01/11/2021 | 1279.31% | HC Wainwright & Co. | $7 → $16 | Maintains | Buy |
| 03/06/2019 | 72.41% | Citigroup | $4.25 → $2 | Maintains | Neutral |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 08/04/2023 | 848.28% | HC Wainwright & Co. | → 11 美元 | 重申 | 購買 → 購買 |
| 05/23/2023 | 503.45% | 貝爾德 | → 7 美元 | 啓動覆蓋開啓 | → 跑贏大盤 |
| 05/05/2023 | 848.28% | HC Wainwright & Co. | → 11 美元 | 重申 | → 購買 |
| 03/03/2023 | 848.28% | HC Wainwright & Co. | → 11 美元 | 重申 | → 購買 |
| 09/07/2022 | 503.45% | 資本一號 | → 7 美元 | 啓動覆蓋開啓 | → 超重 |
| 05/17/2022 | 848.28% | HC Wainwright & Co. | 24 美元 → 11 美元 | 維護 | 購買 |
| 2021 年 12 月 22 日 | 1968.97% | HC Wainwright & Co. | 21 美元 → 24 美元 | 維護 | 購買 |
| 11/22/2021 | 1710.34% | HC Wainwright & Co. | 19 美元 → 21 美元 | 維護 | 購買 |
| 06/07/2021 | 1537.93% | HC Wainwright & Co. | 18 美元 → 19 美元 | 維護 | 購買 |
| 05/06/2021 | 1451.72% | HC Wainwright & Co. | 16 美元 → 18 美元 | 維護 | 購買 |
| 2021 年 4 月 29 日 | 1624.14% | Maxim 集團 | → 20 美元 | 啓動覆蓋開啓 | → 購買 |
| 2021 年 3 月 31 日 | 1710.34% | 傑富瑞 | → 21 美元 | 啓動覆蓋開啓 | → 購買 |
| 2021 年 3 月 31 日 | 1106.9% | Wedbush | → 14 美元 | 啓動覆蓋開啓 | → 跑贏大盤 |
| 2021 年 11 月 1 日 | 1279.31% | HC Wainwright & Co. | 7 美元 → 16 美元 | 維護 | 購買 |
| 03/06/2019 | 72.41% | 花旗集團 | 4.25 美元 → 2 美元 | 維護 | 中立 |
What is the target price for Chimerix (CMRX)?
Chimerix (CMRX) 的目標價格是多少？
The latest price target for Chimerix (NASDAQ: CMRX) was reported by HC Wainwright & Co. on August 4, 2023. The analyst firm set a price target for $11.00 expecting CMRX to rise to within 12 months (a possible 848.28% upside). 5 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 於2023年8月4日公佈了Chimerix（納斯達克股票代碼：CMRX）的最新目標股價。這家分析公司將目標股價定爲11.00美元，預計CMRX將在12個月內升至12個月內（可能上漲848.28％）。去年有5家分析公司公佈了評級。
What is the most recent analyst rating for Chimerix (CMRX)?
分析師對Chimerix（CMRX）的最新評級是多少？
The latest analyst rating for Chimerix (NASDAQ: CMRX) was provided by HC Wainwright & Co., and Chimerix reiterated their buy rating.
Chimerix（納斯達克股票代碼：CMRX）的最新分析師評級由HC Wainwright & Co. 提供，Chimerix重申了他們的買入評級。
When is the next analyst rating going to be posted or updated for Chimerix (CMRX)?
Chimerix（CMRX）的下一個分析師評級何時公佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Chimerix, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Chimerix was filed on August 4, 2023 so you should expect the next rating to be made available sometime around August 4, 2024.
分析師在進行了廣泛的研究（包括瀏覽公開財務報表、與Chimerix的高管和客戶交談以及聽取業績電話會議）後得出股票評級。大多數分析師每三個月進行一次評級，因此每家公司每年應該獲得4個評級。Chimerix的最後一次評級是在2023年8月4日提交的，因此您應該預計下一個評級將在2024年8月4日左右公佈。
Is the Analyst Rating Chimerix (CMRX) correct?
分析師評級 Chimerix (CMRX) 正確嗎？
While ratings are subjective and will change, the latest Chimerix (CMRX) rating was a reiterated with a price target of $0.00 to $11.00. The current price Chimerix (CMRX) is trading at is $1.16, which is within the analyst's predicted range.
雖然評級是主觀的，會發生變化，但最新的Chimerix（CMRX）評級得到了重申，目標股價爲0.00美元至11.00美元。Chimerix（CMRX）目前的交易價格爲1.16美元，在分析師的預測區間內。